Stoke Therapeutics names Ian Smith as permanent CEO
Go back to Stoke Therapeutics names Ian Smith as permanent CEO| (NASDAQ: STOK) | Delayed: 29.92 -0.13 (0.43%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $30.05 | 52 Week High | $ | |||
| Open | $29.53 | 52 Week Low | $ | |||
| Day High | $30.53 | P/E | N/A | |||
| Day Low | $29.53 | EPS | $ | |||
| Volume | 639,813 | |||||

